论文信息 - Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies - 字舞流文

Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies

R. Berger | A. Nagler | M. Leiba | A. Shimoni | A. Kneller | M. Koren-Michowitz | R. Rotem‐Yehudar | G. Slama | S. Landes